Rewiring the PEP-pyruvate-oxaloacetate node through coordinated fine- tuning of gltA and pykF expression for L-threonine production in wild-type Escherichia coli

Life depends on a delicate balance between building a body and fueling it. In the microscopic world of bacteria, this balance is managed by a central hub where carbon, the fundamental building block of life, is sorted into different pathways. Some of this carbon is burned to create energy, while the rest is saved to construct essential molecules like amino acids, the raw materials for proteins. One such amino acid, L-threonine, is vital for humans and many animals because our bodies cannot make it; we must get it from our food. Because of this, scientists have long tried to engineer bacteria to produce L-threonine in large quantities for use in animal feed and supplements. The challenge has always been finding a way to make the bacteria produce more of this amino acid without starving the cells of the energy they need to survive and grow. If the factory works too hard making the product, the workers—the bacteria—collapse. If they focus too much on growing, the product never appears.

For years, the standard approach to solving this problem was to take a sledgehammer to the bacterial metabolism. Researchers would simply delete the genes responsible for competing pathways, effectively cutting off the energy routes to force all the carbon toward L-threonine. However, this blunt force often backfired. By completely removing these competing routes, the bacteria lost their ability to generate energy efficiently, leading to poor growth and low yields. A new study by researchers at the Institute of Microbiology in Guangdong, China, suggests that a more subtle, coordinated approach works far better. Instead of deleting the competing pathways entirely, they learned to fine-tune them, adjusting the flow of carbon like a skilled conductor managing an orchestra rather than silencing the instruments.

The researchers focused on a specific junction in the bacterial cell known as the PEP-pyruvate-oxaloacetate node. Imagine this node as a busy intersection where a stream of carbon molecules must choose between two main roads: one leads to the tricarboxylic acid cycle, a process that generates energy for the cell to grow, and the other leads to the production of L-threonine. In a standard bacterial cell, most of the carbon naturally flows toward energy production, leaving very little for making the amino acid. The two main enzymes acting as traffic controllers at this intersection are citrate synthase and pyruvate kinase. In previous attempts, scientists tried to remove these enzymes completely to block the energy road, but this caused the bacterial cells to stop growing and stop producing the amino acid altogether.

The team realized that the problem was not the existence of these pathways, but the timing of their activity. They needed a way to let the bacteria grow first, using the energy pathways, and then switch the flow to amino acid production once the population was large enough. To achieve this, they did not delete the genes for the traffic controllers. Instead, they rewired the genetic switches that turn these genes on and off. They used special promoters—genetic sequences that act like sensors—to detect the growth phase of the bacteria. During the early, rapid growth phase, these sensors kept the energy pathways fully open, allowing the bacteria to build a strong population. Once the bacteria entered a slower, stationary phase where growth naturally slows down, the sensors automatically reduced the activity of the energy pathways. This subtle shift redirected the excess carbon that was no longer needed for growth directly into the L-threonine production line.

To make this system even more efficient, the researchers combined this dynamic switch with other improvements. They strengthened the specific steps in the chemical chain that convert the raw materials into the final amino acid and ensured the bacteria could export the product out of the cell quickly. They also adjusted the supply of a key precursor molecule to ensure the production line never ran dry. Crucially, they moved all these genetic changes directly into the bacteria's main chromosome, rather than leaving them on small, unstable rings of DNA called plasmids. This made the new strain stable and removed the need for antibiotics or chemical triggers to keep the system running, which is a significant advantage for industrial use.

The results of this coordinated fine-tuning were striking. In a simple laboratory flask, the engineered bacteria produced 28.3 grams of L-threonine per liter of liquid. This was a massive improvement over the control strain, which produced almost nothing. When the researchers moved the process to a larger bioreactor, simulating industrial conditions, the bacteria produced 101.6 grams per liter. The process was highly efficient, converting about 64 percent of the glucose sugar fed to the bacteria into the amino acid. Perhaps most importantly, the bacteria grew just as well as normal cells during the initial phase, proving that the strategy successfully balanced the needs of growth and production without compromising either.

This study demonstrates that in metabolic engineering, precision often beats force. By understanding the natural rhythms of bacterial growth and designing a system that respects those rhythms, the researchers were able to coax the cells into becoming highly efficient factories. They showed that competing pathways do not need to be destroyed to be useful; they simply need to be managed. This approach of fine-tuning rather than deleting could serve as a blueprint for producing other essential amino acids and complex chemicals, offering a more sustainable and effective way to harness the power of microbial life.